A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

Colchicine in Moderate Symptomatic COVID-19 Patients

NCT04527562 ·Status: COMPLETED ·Phase: NA

Anakinra in Dengue With Hyperinflammation ( AnaDen )

NCT05611710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

NCT05366439 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

NCT06574503 ·Status: RECRUITING ·Phase: PHASE3

Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

NCT04730427 ·Status: TERMINATED ·Phase: PHASE1

Singapore SARS-CoV-2 Human Challenge Study

NCT06654973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

NCT04405076 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

NCT04428073 ·Status: UNKNOWN ·Phase: PHASE1

The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497

NCT03726853 ·Status: COMPLETED ·Phase: PHASE2

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

NCT05260437 ·Status: COMPLETED ·Phase: PHASE1

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

NCT06197217 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

NCT04521296 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

NCT06573008 ·Status: RECRUITING ·Phase: PHASE3

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

NCT04676867 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Remdesivir in Adults With Severe COVID-19

NCT04257656 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of PJS-539 for Adult Patients With COVID-19.

NCT05008393 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

NCT05745545 ·Status: UNKNOWN ·Phase: NA

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

NCT01992276 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 ·Status: UNKNOWN ·Phase: PHASE3

Tafenoquine in Patients With Mild to Moderate COVID-19

NCT04533347 ·Status: COMPLETED ·Phase: PHASE2

Study of AT-752 in Patients With Dengue Infection

NCT05466240 ·Status: TERMINATED ·Phase: PHASE2

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

NCT04252664 ·Status: SUSPENDED ·Phase: PHASE3

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

NCT05752175 ·Status: COMPLETED ·Phase: PHASE2

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

NCT04729764 ·Status: COMPLETED ·Phase: PHASE1